Home

Site Search

Presentation Details

Home

Home

Presentation Details

FB102 prevents histological damage and mitigates gluten challenge-induced symptoms in a celiac disease Phase 1b study

September 15, 2025

View this Presentation PDF Format Download (opens in new window) PDF 769 KB Listen to this Presentation Audio Format Download (opens in new window) Watch this Presentation Video Format Download (opens in new window) View this Presentation PDF Format Download (opens in new window)

Home
News
About Us
Investor Relations
Management
Contact Us

Headquarters

Forte Biosciences, Inc.
3060 Pegasus Park Dr.
Building 6
Dallas, TX 75247

inquiry@fortebiorx.com

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Forte Biosciences Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Forte Biosciences Inc to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

Press Releases

Events

Presentations

SEC Filings

End of Day Stock Quote